1AD 0.00% 2.7¢ adalta limited

Ann: AD-214 effective in gold standard pre-clinical animal model, page-2

  1. 1,431 Posts.
    lightbulb Created with Sketch. 97
    This is a cracking announcement, not that it will gain much traction in current market.

    Pre-clinical mouse model showing greater effectiveness from AD-214 as compared to the 2 drugs currently in the market for IPF.

    Still on track for mid-year first patient dosing in the phase 1 trial.

    It's a happy buy and wait for me
    Last edited by Ildsrud: 02/03/20
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $14.39M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $3.452K 127.8K

Buyers (Bids)

No. Vol. Price($)
1 506125 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 506977 2
View Market Depth
Last trade - 10.53am 28/05/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.